Skip to main content
SpringerLink
Log in

Pulmonary hypertension

  • Review
  • Published:
Lung Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. A National Cooperative Study (1973) The urokinase-pulmonary embolism trial. Circulation 47:Suppl:2:1

    Google Scholar 

  2. A National Cooperative Study (1974) Urokinase-streptokinase embolism trial: phase 2 results. JAMA 229:1606

    Article  Google Scholar 

  3. Abraham AS, Cole RB, Bishop JM (1968) Reversal of pulmonary hypertension by prolonged oxygen administration to patients with chronic bronchitis. Circ Res 23:147–157

    PubMed  CAS  Google Scholar 

  4. Abraham AS, Kay JM, Cole RB, Pincock AC (1971) A haemodynamic and pathological study of the effect of chronic hypoxia and subsequent recovery of the heart and pulmonary vasculature of the rat. Cardiovasc Res 5:95–102

    PubMed  CAS  Google Scholar 

  5. Ahmed T, Oliver W Jr (1983) Does slow-reacting substance of anaphylaxis mediate hypoxic pulmonary vasoconstriction? Am Rev Respir Dis 127:566–571

    PubMed  CAS  Google Scholar 

  6. Ahmed T, Oliver W Jr, Frank BL, Robinson MJ, Wanner A (1982) Hypoxic pulmonary vasoconstriction in conscious sheep: role of mast cell degranulation. Am Rev Respir Dis 126:291–297

    PubMed  CAS  Google Scholar 

  7. Alpert JS, Godtfredsen J, Ockeneis IS, et al (1978) Pulmonary hypertension secondary to minor pulmonary embolism. Chest 73:795–797

    PubMed  CAS  Google Scholar 

  8. Aviado DM, Ling JS, Schmidt CF (1957) Effects of anoxia on pulmonary circulation: reflex pulmonary vasoconstriction. Am J Physiol 189:253–262

    PubMed  CAS  Google Scholar 

  9. Bates ER, Crevey BJ, Sprague FR, Pitt B (1981) Oral hydralazine therapy for acute pulmonary embolism and low output. Arch Intern Med 141:1537–1538

    Article  PubMed  CAS  Google Scholar 

  10. Benumof JL, Wahrenbrock EA (1975) Blunted hypoxic pulmonary vasoconstriction by increased lung vascular pressures. J Appl Physiol 38:846–850

    PubMed  CAS  Google Scholar 

  11. Berger HJ, Matthay RA (1981) Noninvasive radiographic assessment of cardiovascular function in acute and chronic respiratory failure. Am J Cardiol 47:950–962

    Article  PubMed  CAS  Google Scholar 

  12. Braun A, Greenberg SD, Malik S, et al (1973) Pulmonary veno-occlusive disease associated with pulmonary phlebitis. Arch Pathol 95:67–70

    PubMed  CAS  Google Scholar 

  13. Brent BN, Berger HJ, Matthay RA, et al (1982) Physiologic correlates of right ventricular ejection fraction in chronic obstructive pulmonary disease: a combined radionuclide and hemodynamic study. Am J Cardiol 50:255–262

    Article  PubMed  CAS  Google Scholar 

  14. Brent BN, Mahler D, Berger HJ, et al (1982) Augmentation of right ventricular performance in chronic obstructive pulmonary disease by terbutaline: a combined radionuclide and hemodynamic study. Am J Cardiol 50:313–319

    Article  PubMed  CAS  Google Scholar 

  15. Brent BN, Matthay RA, Mather DA, Berger HJ, Zaret BL, Lister G (1984) Relationship between oxygen uptake and oxygen transport in stable patients with chronic obstructive pulmonary disease: physiologic effects of nitroprusside and hydralazine. Am Rev Respir Dis 129:682–687

    PubMed  CAS  Google Scholar 

  16. Brodie BR, Grossman W, Mann T, McLaurin LP (1977) Effects of sodium nitroprusside on left ventricular diastolic pressure-volume relations in man. J Clin Invest 59:59–68

    PubMed  CAS  Google Scholar 

  17. Brown SE, Linden GS, Blair GP, Stansbury DW, King RR, Light RW (1983) The effects of verapamil on pulmonary hemodynamics during induced hypoxemia and exercise in patients with obstructive lung disease. Thorax 38:840–844

    PubMed  CAS  Google Scholar 

  18. Byrne-Quinn E, Grover RF (1972) Aminorex and amphetamine: acute and chronic effects on pulmonary and systemic hemodynamics in the calf. Thorax 27:127–131

    PubMed  CAS  Google Scholar 

  19. Carrington CB, Liebow AA (1970) Pulmonary veno-occlusive disease. Hum Pathol 1:322–324

    Article  PubMed  CAS  Google Scholar 

  20. Chawla SK, Kittle CF, Faber LP, et al (1976) Pulmonary veno-occlusive disease. Ann Thorac Surg 22:249–253

    Article  PubMed  CAS  Google Scholar 

  21. Chidsey CA, Braunwald E, Morrow AG (1965) Catecholamine excretion and cardiac stores of norepinephrine in congestive heart failure. Am J Med 39:442–451

    Article  PubMed  CAS  Google Scholar 

  22. Cohen HA, Baird MG, Rouleau JR, et al. (1976) Thallium-201 myocardial imaging in patients with pulmonary hypertension. Circ 54:790–795

    CAS  Google Scholar 

  23. Cullen JH, Kaemmerlen JT, Daoud A, Katz HL (1970) A prospective clinical-pathological study of the lungs and heart in chronic obstructive lung disease. Am Rev Respir Dis 102:190–204

    PubMed  CAS  Google Scholar 

  24. Cystic Fibrosis Foundation Research Program GAP Conference Report (1980). Corpulmonale, 4:3

  25. Dalen JE, Alpert JS (1975) Natural history of pulmonary embolism. Prog Cardiovasc Dis 17:257–270

    Article  Google Scholar 

  26. Dantzker DD, Bower JS (1981) Partial reversibility of chronic pulmonary hypertension caused by pulmonary thromboembolic disease. Am Rev Respir Dis 124:129–131

    PubMed  CAS  Google Scholar 

  27. Davidson A, McMurty I, Reeves JT (1978) Pulmonary vascular effects of verapamil. Am Heart J 95:810–811

    Article  PubMed  CAS  Google Scholar 

  28. Dugard A, Naimark A (1967) Effect of hypoxia on distribution of pulmonary blood flow. J Appl Physiol 23:663–671

    PubMed  CAS  Google Scholar 

  29. Dunnill MS (1961) An assessment of the anatomical factor in pulmonary emphysema. J Clin Pathol 14:246–258

    Article  PubMed  CAS  Google Scholar 

  30. Fishman AP (1974) Dietary pulmonary hypertension. Circ Res 35:657–660

    PubMed  CAS  Google Scholar 

  31. Fishman AP (1976) Hypoxia on the pulmonary circulation: how and where it acts. Circ Res 38:221–231

    PubMed  CAS  Google Scholar 

  32. Fishman AP, Pietra GG (1980) Primary pulmonary hypertension. Annu Rev Med 31:421–431

    Article  PubMed  CAS  Google Scholar 

  33. Fritts HW Jr, Odell JE, Harris P, Braunwald EW, Fishman AP (1960) Effects of acute hypoxia on the volume of blood in the thorax. Circulation 22:216–219

    PubMed  Google Scholar 

  34. Gamble WJC, Phornphutkul C, Kumar AE, Sanders GL, Manasek FJ, Monroe RG (1973) Ventricular performance, coronary flow, and MV2 in aortic coarctation hypertrophy. Am J Physiol 224:877–883

    PubMed  CAS  Google Scholar 

  35. Genovesse A, Chiariello M, Cacciapuoti AA, et al. (1980) Inhibition of hypoxia-induced cardiac hypertrophy by verapamil in rats. Basic Res Cardiol 75:757–763

    Article  Google Scholar 

  36. Goldberg HL, Tamari I (1983) Nifedipine in pulmonary hypertension: importance of Raynaud’s phenomenon (abstr). Circulation 68 (Suppl III):III-36

    Google Scholar 

  37. Grant BJ, Davies EE, Jones HA, Hughes JMB (1976) Local regulation of pulmonary blood flow and ventilation-perfusion ratios in the coatimundi. J Appl Physiol 40:216–228

    PubMed  CAS  Google Scholar 

  38. Gregoratos G, Karliner JA, Moser KM (1979) Mechanisms of disease and methods of assessment. In: Moser KM (ed) Pulmonary vascular diseases. Marcel Dekker, Inc, New York, p 279

    Google Scholar 

  39. Gregory TJ, Newell JC, Hakim TS, et al (1982) Attenuation of hypoxic pulmonary vasoconstriction by pulsatile flow in dog lungs. J Appl Physiol 53:1583–1588

    PubMed  CAS  Google Scholar 

  40. Guilleminault C, Tilkian A, Dement WC (1976) The sleep apnea syndromes. Annu Rev Med 27:465–484

    Article  PubMed  CAS  Google Scholar 

  41. Gupta BD, Moodie DS, Hodgman JR (1980) Primary pulmonary hypertension in adults. Clev Clin Q 47:275–284

    CAS  Google Scholar 

  42. Gurnter HP (1969) Pulmonary hypertension produced by the ingestion of substances. Bull Physiol Pathol Respir 5:435

    Google Scholar 

  43. Haack DW, Abel FM, Jaenke RS (1973) Effects of hypoxia on the distribution of calcium in arterial smooth muscle cells of rats and swine. Cell Tissue Res 157:125–140

    Google Scholar 

  44. Haas F, Bergofsky EH (1972) Role of mast cell in the pulmonary pressor response to hypoxia. J Clin Invest 51:3154–3162

    PubMed  CAS  Google Scholar 

  45. Harabin AL, Peake MD, Sylvester JT (1981) Effect of severe hypoxia on the pulmonary vascular response to vasoconstrictor agents. J Appl Physiol 50:561–566

    PubMed  CAS  Google Scholar 

  46. Harris P, Heath D (1977) The human pulmonary circulation. Churchill-Livingstone, New York, p 418

    Google Scholar 

  47. Harris P and Heath D (1977) The human pulmonary circulation. Churchill-Livingstone, New York, p 504

    Google Scholar 

  48. Hasleton P, Health D, Brewer DB (1968) Hypertensive pulmonary vascular disease in states of chronic hypoxia. J Pathol 95:431–440

    Article  CAS  Google Scholar 

  49. Hatano S, Strasser T. eds (1975) Primary pulmonary hypertension. Report on WHO Meeting. World Health Organization, Geneva, p 45

    Google Scholar 

  50. Hauge A (1969) Hypoxia and pulmonary vascular resistance. The relative effects of pulmonary arterial and alveolar PO2. Acta Physiol Scand 76:121–130

    PubMed  CAS  Google Scholar 

  51. Heath D (1980) Ultrastructure in pulmonary hypertension. In: Cumming G, Bonsignore G (eds) Pulmonary circulation in health and disease. Plenum Press, New York, p 233

    Google Scholar 

  52. Heath D, Edwards JE (1958) The pathology of hypertensive pulmonary vascular disease. Circulation 18:533–547

    PubMed  CAS  Google Scholar 

  53. Heath DA, Williams DD (1977) Man at high altitude. Churchill-Livingstone, New York

    Google Scholar 

  54. Hermiller JB, Bambach D, Thompson MJ, et al (1982) Vasodilators and prostaglandin inhibitors in primary pulmonary hypertension. Ann Intern Med 97:480–489

    PubMed  CAS  Google Scholar 

  55. Hicken P, Heath D, Brewer DB, Whitaker W (1965) The small pulmonary arteries in emphysema. J Pathol 90:107–114

    Article  CAS  Google Scholar 

  56. Hislop A, Reid L (1976) New findings in pulmonary arteries of rats with hypoxia induced pulmonary hypertension. Br J Exp Pathol 57:542–554

    PubMed  CAS  Google Scholar 

  57. Holtz J, Restorff W, Bard P, Bassenge E (1977) Transmural distribution of myocardial blood flow and of coronary reserve in canine left ventricular hypertrophy. Basic Res Cardiol 72:286–292

    Article  PubMed  CAS  Google Scholar 

  58. Honey M, Cotten L, Davies N, Denison D (1980) Clinical and hemodynamic effects of diazoxide in primary pulmonary hypertension. Thorax 35:269–276

    PubMed  CAS  Google Scholar 

  59. Hood HB Jr, Spencer H, Lass RW, Daley R (1968) Primary pulmonary hypertension: familial occurrence. Br Heart J 30:336–343

    Article  PubMed  Google Scholar 

  60. Hottenstein O, Mitzner W, Bierkamper GG (1982) Hypoxia alters membrane potentials in rat main pulmonary artery smooth muscle: a possible calcium mechanism (abstr). Physiologist 25:276

    Google Scholar 

  61. Hultgren HN, Grover RF (1968) Circulatory adaption to high altitude. Annu Rev Med 19:119–152

    Article  PubMed  CAS  Google Scholar 

  62. Kato M, Staub NC (1966) Response of small pulmonary arteries to unilobar hypoxia and hypercapnia. Circ Res 19:426–440

    PubMed  CAS  Google Scholar 

  63. Kay JM (1980) Effect of intermittent normoxia on chronic hypoxic pulmonary hypertension, right ventricular hypertrophy, and polycythemia in rats. Am Rev Respir Dis 121:993–1001

    PubMed  CAS  Google Scholar 

  64. Kay JM, Smith P, Heath D (1971) Aminorex and the pulmonary circulation. Thorax 26:262–270

    PubMed  CAS  Google Scholar 

  65. Kay JM, Suyma KL, Keane PM (1981) Effect of intermittent normoxia on muscularization of pulmonary arterioles induced by chronic hypoxia in rats. Am Rev Respir Dis 123:454–458

    PubMed  CAS  Google Scholar 

  66. Kennedy T, Summer W (1982) Inhibition of hypoxic pulmonary vasoconstriction by nifedipine. Am J Cardiol 50:864–868

    Article  PubMed  CAS  Google Scholar 

  67. Kennedy TP, Michael JR, Haung CK, et al (1983) Nifedipine inhibits hypoxic pulmonary vasoconstriction during rest and exercise in patients with chronic obstructive pulmonary disease: a controlled double-blind study. Am Rev Respir Dis 129:544–551

    Google Scholar 

  68. Kentera D, Susic D, Zdravkovic M (1979) Effects of verapamil and aspirin on experimental chronic hypoxic pulmonary hypertension and right ventricular hypertrophy in rats. Respiration 37:192–196

    PubMed  CAS  Google Scholar 

  69. Klinke WB, Gilbert JAL (1980) Diazoxide in primary pulmonary hypertension. N Engl J Med 302:91–92

    Article  PubMed  CAS  Google Scholar 

  70. Knapp RS, Mullins CB (1972) Progressive tricuspid regurgitation as a limit to right ventricular output in acute pulmonary hypertension (abstr). Clin Res 20:69

    Google Scholar 

  71. Knoblauch A, Sybert A, Brennan JN, et al (1981) Effect of hypoxia and CO on a cytochrome P-450 mediated reaction in rabbit lungs. J Appl Physiol 51:1635–1642

    PubMed  CAS  Google Scholar 

  72. Kronzon I, Cohen M, Winer HE (1982) Adverse effect of hydralazine in patients with primary pulmonary hypertension. JAMA 247:3112–3114

    Article  PubMed  CAS  Google Scholar 

  73. Laros CO, Swierenga J (1967) Temporary unilateral pulmonary artery occlusion in the preoperative evaluation of patients with bronchial carcinoma. Med Thorax 24:269–283

    CAS  Google Scholar 

  74. Leach E, Howard P, Barer GR (1977) Resolution of hypoxia changes in the heart and pulmonary arterioles of rats during intermittent correction of hypoxia. Clin Sci Mol Med 52:153–162

    PubMed  CAS  Google Scholar 

  75. Lebrec D, Capron JP, Dhumeaux, Benhamou JP (1970) Pulmonary hypertension complicating portal hypertension. Am Rev Respir Dis 120:849–856

    Google Scholar 

  76. Leland OS, Sashara AA (1965) Hemodynamic observations in patients with pulmonary thromboembolism. In: Sashara A, Stein M (eds) Pulmonary emoboli disease. Grune and Stratton, New York, p 110

    Google Scholar 

  77. Levitsky MG (1979) Chemoreceptor stimulation and hypoxic pulmonary vasoconstriction in conscious dogs. Respir Physiol 37:151–160

    Article  Google Scholar 

  78. Levitzky MG, Newell JC, Dutton RE (1978) Effect of chemoreceptor denervation on the pulmonary vascular response to atelectasis. Respir Physiol 35:43–51

    Article  PubMed  CAS  Google Scholar 

  79. Levitsky MG, Newell JC, Krasney JA, Dutton RE (1977) Chemoreceptor influence on pulmonary blood flow during unilateral hypoxia in dogs. Respir Physiol 31:345–356

    Article  Google Scholar 

  80. Linzbach AJ (1960) Heart failure from the point of view of quantitaive anatomy. Am J Cardiol 5:370–382

    Article  PubMed  CAS  Google Scholar 

  81. Lloyd TC Jr (1966) Role of nerve pathways in the hypoxic vasoconstriction of lung. J Appl Physiol 21:1351–1355

    PubMed  Google Scholar 

  82. Lloyd TC Jr (1968) Hypoxic pulmonary vasoconstriction: role of perivascular tissue. J Appl Physiol 25:560–565

    PubMed  Google Scholar 

  83. Lopez-Majano V, Wagner HN, Twinning RH, Tow DE, Chernick V (1966) Effect of regional hypoxia on the distribution of pulmonary blood flow in man. Circ Res 18:550–557

    PubMed  CAS  Google Scholar 

  84. Lowensohn HS, Khouri EM, Gregg, DE, et al (1976) Phasic right coronary artery blood flow in conscious dogs with normal and elevated right ventricular pressure. Circ Res 39:760–766

    PubMed  CAS  Google Scholar 

  85. Loyd JE, Primm RK, Newman JH (1983) Familial primary pulmonary hypertension: clinical patterns. Am Rev Respir Dis 129:194–197

    Google Scholar 

  86. Ludbrook PA, Byrne JD, McKnight RC (1979) Influence of right ventricular hemodynamics on left ventricular diastolic pressure-volume relations in man. Circulation 59:21–31

    PubMed  CAS  Google Scholar 

  87. Lupi-Herrera E, Sandoral J, Seoane M, Bialostosky D (1982) The role of hydralazine therapy for pulmonary arterial hypertension of unknown cause. Circulation 65:645–650

    PubMed  CAS  Google Scholar 

  88. McDonnell PJ, Summer WR, Hutchins GM (1981) Pulmonary veno-occlusive disease: morphological changes suggesting a viral cause. JAMA 246:667–671

    Article  PubMed  CAS  Google Scholar 

  89. McDonnell PJ, Toye PA, Hutchins GM (1983) Primary pulmonary hypertension and cirrhosis: are they related? Am Rev Respir Dis 127:437–441

    PubMed  CAS  Google Scholar 

  90. McIntyre KM, Sasahara AA (1971) Hemodynamic alterations related to extent of lung scan perfusion. J Nucl Med 12:166–170

    PubMed  CAS  Google Scholar 

  91. McIntyre KM, Sasahara AA (1973) Determinants of the cardiovascular response to pulmonary embolism. In: Moser K, Stein (eds) Pulmonary thromboembolism. Year Book Medical Publishers, Chicago, p 144

    Google Scholar 

  92. McIntyre KM, Sasahara AA (1977) The ratio of pulmonary arterial pressure to pulmonary vascular obstruction. Chest 71:692–697

    PubMed  CAS  Google Scholar 

  93. McMurtry IF, Davidson AB, Reeves JT, Grover R (1976) Inhibition of hypoxic pulmonary vasoconstriction by calcium antagonists in isolated rat lungs. Circ Res 38:99–104

    PubMed  CAS  Google Scholar 

  94. McMurtry IF, Reeves JT, Will DH, Grover RF (1977) Reduction in bovine pulmonary hypertension by normoxia, verapamil and hexaprenaline. Experientia 33:1192–1194

    Article  PubMed  CAS  Google Scholar 

  95. McMurty IF, Stanbrook HS, Round S (1982) The mechanism of hypoxic pulmonary vasoconstriction: a working hypothesis. In: Loeppky JA, Riedesel ML (eds) Oxygen transport to human tissues. Elsevier North Holland, Inc, p 78

  96. Malik AB, Abe T, O’Kane H, Geha AS (1973) Cardiac function, coronary flow, and oxygen consumption in stable left ventricular hypertrophy. Am J Physiol 225:186–191

    PubMed  CAS  Google Scholar 

  97. Marcus ML, Eckberg DL, Braxmeier JL, Abboud FM (1977) Effects of intermittent pressure loading on the development of ventricular hypertrophy in the cat. Circ Res 40:484–488

    PubMed  CAS  Google Scholar 

  98. Marshall BE and Marshall C (1980) Continuity of response to hypoxic pulmonary vasoconstriction. J Appl Physiol 49:189–196

    PubMed  CAS  Google Scholar 

  99. Meerson FZ, Pshennikova MG (1965) Effect of myocardial hypertrophy on cardiac contractility. Fed Proc [Transl Suppl] 24:957–959

    CAS  Google Scholar 

  100. Melmon KL, Braunwald E (1963) Familial pulmonary hypertension. N Engl J Med 269:770–775

    Article  PubMed  CAS  Google Scholar 

  101. Meyrick B, Reid L (1978) The effect of continued hypoxia on rat pulmonary artery circulation. Lab Invest 38:188–200

    PubMed  CAS  Google Scholar 

  102. Michael JR, Kennedy TP, Fitzpatrick S, Rosenstein B (1984) Nifedipine inhibits hypoxic pulmonary vasoconstriction during rest and exercise in patients with cor pulmonale from cystic fibrosis. Am Rev Respir Dis 130:516–519

    PubMed  CAS  Google Scholar 

  103. Mitzner W (1983) Resistance of the pulmonary circulation. Clin Chest Med 4:127–137

    PubMed  CAS  Google Scholar 

  104. Morrison EB, Gaffney FA, Eigenbrodt, et al (1980) Severe pulmonary hypertension associated with macronodular cirrhosis and autoimmune phenomena. Am J Med 69:513–519

    Article  PubMed  CAS  Google Scholar 

  105. Mueller TM, Marcus ML, Kerber RE, Young JA, Barnes RW, Abboud FM (1978) Effect of renal hypertension and left ventricular hypertrophy on the coronary circulation in dogs. Circ Res 42:543–549

    PubMed  CAS  Google Scholar 

  106. Murray PA, Vatner SF (1980) Reduction of maximal coronary vasodilator capacity in conscious dogs with severe right ventricular hypertrophy. Circ Res 48:25–33

    Google Scholar 

  107. Murray PA, Vatner SF (1981) Abnormal coronary vascular response to exercise in dogs with severe right ventricular hypertrophy. J Clin Invest 67:1314–1323

    PubMed  CAS  Google Scholar 

  108. Murray PA, Vatner SF (1981) Carotid sinus baroreceptor control of right coronary circulation in normal, hypertrophied, and ailing right ventricles of conscious dogs. Circ Res 49:1339–1349

    PubMed  CAS  Google Scholar 

  109. Murray PA, Vatner SF (1983) Reflex cardiovascular responses to carotid chemoreceptor activation in conscious dogs with right ventricular hypertrophy. Am J Physiol 245:H871–879

    PubMed  CAS  Google Scholar 

  110. Oksuza F, Handa S, Kondo M, et al (1980) Thallium-201 myocardial imaging to evaluate right ventricular overloading. Circ 61:620–625

    Google Scholar 

  111. O’Keefe DD, Hoffman JIE, Cheitlin R, O’Neill MJ, Allard JR, Shapkin E (1978) Coronary blood flow in experimental canine left ventricular hypetrophy. Circ Res 43:43–51

    PubMed  CAS  Google Scholar 

  112. Olivari MT, Levine TB, Weir EK, Cohn JN (1984) Hemodynamic effects of nifedipine at rest and during exercise in primary pulmonary hypertension. Chest 86:14–20

    PubMed  CAS  Google Scholar 

  113. Ostadal B, Ressl J, Urbanova D, et al (1981) Effect of verapamil on pulmonary hypertension and right ventricular hypertrophy induced in rats by intermittent high altitude hypoxia. Respiration 42:221–227

    PubMed  CAS  Google Scholar 

  114. Packer M, Greenberg B, Massie B, Dash H (1982) Deleterious effects of hydralazine in patients with pulmonary hypertension. N Engl J Med 22:1326–1331

    Article  Google Scholar 

  115. Pietro DA, LaBrash KA, Shulman RM, Folland ED, Paris AF, Sasahara AA (1984) Sustained improvement in primary pulmonary hypertension during six years of treatment with sublingual isoproterenol. N Engl J Med 310:1032–1039

    Article  PubMed  CAS  Google Scholar 

  116. Rabinovitch M, Gamble W, Miettinen OS, Reid L (1981) Age and sex influence on pulmonary hypertension of chronic hypoxia and on recovery. Am J Physiol 240:H62–72

    PubMed  CAS  Google Scholar 

  117. Rabinovitch M, Gamble W, Nadas AS, et al (1979) Rat pulmonary circulation after chronic hypoxia: hemodynamic and structural features. Am J Physiol 236:H818–827

    PubMed  CAS  Google Scholar 

  118. Rambihar VS, Fallen EL, Cairns JA (1979) Pulmonary veno-occlusive disease: antemortem diagnosis from roentgenographic and hemodynamic findings. Can Med Assoc J 120:1519–1522

    PubMed  CAS  Google Scholar 

  119. Rees HA, Thomas AJ, Rossiter C (1964) The recognition of coronary heart disease in the presence of pulmonary disease. Br Heart J 26:233–240

    Article  PubMed  CAS  Google Scholar 

  120. Reid LM (1979) The pulmonary circulation: remodeling in growth and disease. Am Rev Respir Dis 119:531–546

    PubMed  CAS  Google Scholar 

  121. Reitz BA, Walwork JL, Hunt SA, et al (1982) Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease. N Engl J Med 306:557–664

    Article  PubMed  CAS  Google Scholar 

  122. Rembert JC, Kleinman LH, Fedor JM, Wechsler AS, Greenfield JC Jr (1978) Myocardial blood flow distribution in concentric left ventricular hypertrophy. J Clin Invest 62:379–386

    PubMed  CAS  Google Scholar 

  123. Richter GW, Kellner (1963) Hypertrophy of the human heart at the level of fine structure. J Cell Biol 18:195–206

    Article  PubMed  CAS  Google Scholar 

  124. Riedel M, Stanek V, Widimsky J, et al (1982) Longterm follow-up of patients with pulmonary thromboembolism Chest 81:151–158

    CAS  Google Scholar 

  125. Rubin LJ, Peter RH (1980) Oral hydralazine therapy for primary pulmonary hypertension. N Engl J Med 302:69–73

    Article  PubMed  CAS  Google Scholar 

  126. Rubin LJ, Peter RH (1981) Hemodynamics at rest and during exercise after oral hydralazine in patients with cor pulmonale. Am J Cardiol 47:116–122

    Article  PubMed  CAS  Google Scholar 

  127. Rubin LJ, Nicod P, Hillis D, Firth BG (1984) Treatment of primary pulmonary hypertension with nifedipine: a hemodynamic and scientigraphic evaluation. Ann Intern Med 99:433–438

    Google Scholar 

  128. Ruskin JN, Hutter AM Jr (1979) Primary pulmonary hypertension treated with oral phentolamine. Ann Intern Med 90:772–774

    PubMed  CAS  Google Scholar 

  129. Sackler JP, Liu L (1972) A case of pulmonary veno-occlusive disease—etiological and therapeutic appraisal. Angiology 23:299

    Google Scholar 

  130. Sackner MA, Akgun N, Kimbel P, et al (1964) The pathophysiology of scleroderma involving the heart and respiratory system. Ann Intern Med 60:611–630

    PubMed  CAS  Google Scholar 

  131. Sanderson JE, Spiro SG, Hendry AT, et al (1977) A case of pulmonary veno-occlusive disease responding to treatment with azathioprine. Thorax 32:140–148

    PubMed  CAS  Google Scholar 

  132. Sasayama S, Franklin D, Ross J (1977) Hyperfunction with normal inotropic state of the hypertrophied left ventricle. Am J Physiol 232:H418–425

    PubMed  CAS  Google Scholar 

  133. Sasayama S, Ross J Jr, Franklin D, et al (1976) Adaptations of the left ventricle to chronic pressure overload. Circ Res 38:172–178

    PubMed  CAS  Google Scholar 

  134. Savajiyani R, Benchimol A, Desser KB (1981) Primary pulmonary hypertension. Arizona Med 38:898–901

    PubMed  CAS  Google Scholar 

  135. Semmens M and Reid L (1974) Pulmonary arterial muscularity and right ventricular hypertrophy in chronic bronchitis and emphysema. Br J Dis Chest 68:253–263

    Article  PubMed  CAS  Google Scholar 

  136. Sharma GV, Burleson VA, Sasahara AA (1980) Effect of thrombolytic therapy on pulmonary capillary blood volume in patients with pulmonary embolism. N Engl J Med 303:842–845

    Article  PubMed  CAS  Google Scholar 

  137. Sime F, Penaloza O, Ruiz L (1971) Bradycardia, increased cardiac output and reversal of pulmonary hypertension in altitude natives living at sea level. Br Heart J 33:647–657

    Article  PubMed  CAS  Google Scholar 

  138. Spann JF, Buccino RA, Sonnenblick EH, Braunwald E (1967) Contractile state of cardiac muscle obtained from cats with experimentally produced ventricular hypertrophy and heart failure. Circ Res 21:341–354

    PubMed  Google Scholar 

  139. Stanek V, Riedel M, Widemsky J (1978) Hemodynamic monitoring in acute pulmonary embolism. Bull Eur Physiopathol Respir 14:561–572

    PubMed  CAS  Google Scholar 

  140. Stein M, Levy SE (1974) Reflex humoral responses to pulmonary embolism. Prog Cardiovasc Dis 17:167–174

    Article  PubMed  CAS  Google Scholar 

  141. Stevens PM, Terplan M, Knowles JH (1963) Prognosis of cor pulmonale. N Eng J Med 269:1289–1291

    Article  CAS  Google Scholar 

  142. Suggett AJ, Herget J (1977) Effect of alpha methyldopa on the pulmonary vascular changes induced by chronic hypoxia in rats. Clin Sci Mol Med 53:397–400

    PubMed  CAS  Google Scholar 

  143. Suggett AJ, Mohammed FH, Barer GR (1980) Angiotensin, hypoxia, verapamil and pulmonary vessels. Clin Exp Pharmacol Physiol 7:263–274

    Article  PubMed  CAS  Google Scholar 

  144. Summer W, Lappe D, Change D, et al (1979) Reduction of pulmonary vascular resistance with intravenous nitroglycerine (abstr). Am Rev Respir Dis 119:389

    Google Scholar 

  145. Summer WR, Michael J, Brinker J (1982) Initial and long term effects of nifedipine in primary pulmonary hypertension (abstr). Chest 82:5145

    Google Scholar 

  146. Sylvester JT, McGowan C (1978) The effects of agents that bind to cytochrome P-450 on hypoxic pulmonary vasoconstriction. Circ Res 43:429–437

    PubMed  CAS  Google Scholar 

  147. Sylvester JT, Harabin AL, Peake MD, Frank RS (1980) Vasodilator and constrictor responses to hypoxia in isolated pig lungs. J Appl Physiol 49:820–825

    PubMed  CAS  Google Scholar 

  148. Symchych PS (1971) Pulmonary hypertension in cystic fibrosis. Arch Pathol 92:409–414

    PubMed  CAS  Google Scholar 

  149. Szidon JP, Fishman AP (1969) Autonomic control of the pulmonary circulation and interstitial space. In: Fishman AP, Hecht HH (eds) University of Chicago Press, Chicago, p 239

    Google Scholar 

  150. Thadani U, Burrow C, Whitaker W, Heath D (1975) Pulmonary venoocculsive disease. Q J Med 173:133–159

    Google Scholar 

  151. Thomas DP, Gurewich V, Ashford TP (1966) Platelet adherence to thromboemboli in relation to the pathogenesis and treatment of pulmonary embolism. N Engl J Med 274:953–956

    Article  PubMed  CAS  Google Scholar 

  152. Thomas DP, Skin M, Tanabe G, Rege V, Wassler S (1964) Mechanism of bronchoconstriction produced by thromoboemboli in dogs. Am J Physiol 206:1207–1212

    PubMed  CAS  Google Scholar 

  153. Tibbutt DA, Davies JA, Anderson JA, et al (1974) Comparison by controlled clinical trial of streptokinase and heparin in treatment of life-threatening pulmonary embolism. Br Med J 1:343–347

    PubMed  CAS  Google Scholar 

  154. Tingelstad JB, Aterman K, Lambert EC (1969) Pulmonary venous obstruction. Report of a case mimicking primary pulmonary artery hypertension, with a review of literature. Am J Dis Child 117:219–227

    PubMed  CAS  Google Scholar 

  155. Tucker A, McMurtry IF, Grover RF, Reeves JT (1976) Attenuation of hypoxic pulmonary vasoconstriction by verapamil in intact dogs. Proc R Soc Biol Med 151:611–614

    CAS  Google Scholar 

  156. Voelkel NF, Reeves RJ (1979) Primary pulmonary hypertension. In: Moser KM (ed) Pulmonary vascular disease. Marcel Dekker, Inc., New York, p 573

    Google Scholar 

  157. Voelkel NF, McMurtry IF, Reeves JT (1980) Chronic propranolol treatment blunts right ventricular hypertrophy in rats at high altitude. J Appl Physiol 48:473–478

    PubMed  CAS  Google Scholar 

  158. Voelkel NF, Morris KG, McMurtry IF, Reeves JT (1980) Calcium augments hypoxic vasoconstriction in lungs from high altitude rats. J Appl Physiol 49:450–455

    PubMed  CAS  Google Scholar 

  159. Von Euler US, Liljestrand G (1946) Observation of the pulmonary arterial blood pressure in the cat. Acta Physiol Scand 12:301–320

    Article  Google Scholar 

  160. Walcott G, Burchell HB, Brown AL, Jr (1970) Primary pulmonary hypertension. Am J Med 49:70–79

    Article  PubMed  CAS  Google Scholar 

  161. Weber KT, Janicki JS, Shroff SG, et al (1981) Contractile mechanics and interactions of the right and left ventricles. Am J Cardiol 47:685–695

    Google Scholar 

  162. Weber KT, Janicki JS, Shroff SG, et al (1983) The right ventricle: physiologic and pathophysiologic considerations. Crit Care Med 11:323–328

    Article  PubMed  CAS  Google Scholar 

  163. Weber KT, Kinasewitz GT, Janicki JT, et al (1982) Oxygen utilization and ventilation during exercise in patients with chronic cardiac failure. Circulation 65:1213–1223

    PubMed  CAS  Google Scholar 

  164. Weir EK (1978) Does normoxic vasodilation rather than hypoxic vasoconstriction account for the pulmonary pressor response to hypoxia? Lancet 1:476–477

    Article  PubMed  CAS  Google Scholar 

  165. Wetzel RC, Sylvester JT (1983) Gender differences in hypoxic vascular response of isolated sheep lungs. J Appl Physiol 55:100–104

    PubMed  CAS  Google Scholar 

  166. Widgren S (1977) Pulmonary hypertension related to aminorex intake. Curr Top Pathol 64:1–64

    PubMed  CAS  Google Scholar 

  167. Wilhemsen L, Selander S, Soderholm B, et al (1963) Recurrent pulmonary embolism. Medicine 42:335–355

    Article  Google Scholar 

  168. Williams JF, Potter RD (1974) Normal contractile state of hypertrophied myocardium after pulmonary artery constriction in the cat. J Clin Invest 54:1266–1272

    Article  PubMed  Google Scholar 

  169. Wong DF, Nataragjan TK, Koller D, et al (1983) Intravenous krypton-81m for continuous monitoring of right ventricular function (abstr). J Am Coll Cardiol 1:578

    Google Scholar 

  170. Yin FC, Guzman PA, Brin KP, et al (1983) Effect of nitroprusside on hydraulic vascular loads on the right and left ventricle of patients with heart failure. Circulation 67:1330–1339

    PubMed  CAS  Google Scholar 

  171. Zakheim RM, Mattioli L, Molteni A, Mullis KB, Bartley J (1975) Prevention of pulmonary vascular changes of chronic alveolar hypoxia by inhibition of angiotensin. Lab Invest 33:57–61

    PubMed  CAS  Google Scholar 

  172. Zasslow MA, Benumof JL, Trousdale FR (1982) Hypoxic pulmonary vasoconstriction and the size of the hypoxic compartment. J Appl Physiol 53:626–630

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Medicine and Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions, USA

    John R. Michael & Warren R. Summer

  2. the Department of Medicine, Louisana State University School of Medicine, Baltimore, Maryland

    John R. Michael & Warren R. Summer

  3. New Orleans, Louisana

    John R. Michael & Warren R. Summer

Authors
  1. John R. Michael
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Warren R. Summer
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Michael, J.R., Summer, W.R. Pulmonary hypertension. Lung 163, 65–82 (1985). https://doi.org/10.1007/BF02713809

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02713809

Key words

Search

Navigation